Active Vitamin D Treatment for Reduction of Residual Proteinuria: A Systematic Review

Despite renin-angiotensin-aldosterone system blockade, which retards progression of CKD by reducing proteinuria, many patients with CKD have residual proteinuria, an independent risk factor for disease progression. We aimed to address whether active vitamin D analogs reduce residual proteinuria. We...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the American Society of Nephrology 2013-11, Vol.24 (11), p.1863-1871
Hauptverfasser:	DE BORST, Martin H, HAJHOSSEINY, Reza, TAMEZ, Hector, WENGER, Julia, THADHANI, Ravi, GOLDSMITH, David J. A
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Biological and medical sciences Clinical Epidemiology Humans Medical sciences Nephrology. Urinary tract diseases Proteinuria - drug therapy Randomized Controlled Trials as Topic Renal Insufficiency, Chronic - drug therapy Renal Insufficiency, Chronic - physiopathology Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland Vitamin D - analogs & derivatives Vitamin D - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!